Stock Taper
SCNI
SCINAI IMMUNOTHERAPEUTICS LTD.
NASDAQ
$2.51
▼ DOWN 6.34% (-0.17)

KEY STATISTICS

Market Cap$1.30 M
52w High$16.80
52w Low$2.15
Dividend Yield
Frequency
P/E-0.18
Volume36.90K
Shares Out.516.94K

COMPANY

LEADERSHIP

Amir Reichman
CHIEF EXECUTIVE
Amir Reichman

ABOUT

SECTOR
Healthcare
WENT PUBLIC
May 11, 2015
METHOD OF GOING PUBLIC
SPAC
FULL TIME EMPLOYEES
45

UPCOMING EARNINGS

DateDec 2, 2026
DayWednesday
Rev. Est.$494.55K
DEC
2
WED

SPLIT RECORD

DATETYPERATIO
2026-08-21Reverse1:10
2024-05-21Reverse1:10
2022-11-25Reverse1:10

PRICE

$2.51 ▼ DOWN 6.34% (−$0.17)
OVERLAYS
$2.50$2.60$2.709:30 AM10:34 AM11:39 AM12:43 PM1:47 PM2:52 PM3:56 PM2.51

About Scinai Immunotherapeutics Ltd.

https://www.scinai.com ↗

Scinai Immunotherapeutics Ltd., based in Jerusalem, develops and commercializes antibody-based therapies for infectious and autoimmune diseases, including COVID-19 NanoAbs, through collaborations with Max Planck and University Medical Center Götti...

INDUSTRY

Biotechnology

A SERVICE SCINAI IMMUNOTHERAPEUTICS LTD. IS KNOWN FOR

Scinai BioServices - Contract Development and Manufacturing Organization (CDMO)

Scinai Immunotherapeutics's Scinai BioServices provides boutique CDMO support from early research to cGMP manufacturing for biotech clients, driving major revenue growth.

Revenue by Products

IconPRODUCTFY2024
License$100K

ETFS HOLDING THIS STOCK

ETFS HOLDING
1
LISTED HERE
1
RANKED BY POSITION SIZE

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow4
Return On Equity1
Return On Assets1
Debt To Equity2
Price To Earnings1
Price To Book1
Overall Score2

INSIDER TRADES

DIRECTOR
GERMAIN MARK
Purchase · 120.0M shares
2026-06-16
DIRECTOR, OFFICER: CHIEF EXECUTIVE OFFICER
Reichman Amir
Purchase · 400.0M shares
2026-06-16
OFFICER: CHIEF OPERATING OFFICER
Mark Elad
· —
2026-03-18
OFFICER: CHIEF OPERATING OFFICER
Mark Elad
· 13.5M shares
2026-03-18

SECTORS PEERS

PEERPRICE
INDP$1.14COMPARE
JSPR$0.70COMPARE
REVB$1.05COMPARE
ONCO$0.61COMPARE
ENVB$1.37COMPARE
SPRC$6.58COMPARE
SLXN$0.36COMPARE
PBM$4.21COMPARE